Release Date: 11/03/16 16:03 Summary: Notice under section 630(2) of the Corporations Act Price Sensitive: Yes Download Document 246.55KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%